Core Insights - Aimeike's stock price increased by 2.04% to 159.69 CNY per share as of November 11, with a total market capitalization of 48.32 billion CNY [1] - The company has experienced a year-to-date stock price decline of 10.04%, but a recent 5-day increase of 5.11% [1][2] - Aimeike's main business involves the research, production, and sales of biomedical soft tissue repair materials, with a revenue composition primarily from injection products [1] Financial Performance - For the period from January to September 2025, Aimeike reported a revenue of 1.865 billion CNY, a year-on-year decrease of 21.49%, and a net profit of 1.093 billion CNY, down 31.05% year-on-year [2] - Cumulative cash dividends since Aimeike's A-share listing amount to 3.887 billion CNY, with 3.012 billion CNY distributed over the past three years [3] Shareholder Information - As of October 31, 2025, Aimeike had 57,400 shareholders, an increase of 2.63% from the previous period, with an average of 3,630 circulating shares per shareholder, a decrease of 2.56% [2] - Major shareholders include Hong Kong Central Clearing Limited and various ETFs, with notable reductions in their holdings [3]

Core Viewpoint - The consumer sector is showing signs of recovery, driven by favorable policies, rising CPI, and the imminent closure of Hainan Free Trade Port, leading to increased investment enthusiasm in the sector [2][4]. Group 1: Consumer Sector Analysis - The consumer sector is believed to be at the bottom, with fundamentals gradually improving, as indicated by the third-quarter reports [4]. - The "14th Five-Year Plan" emphasizes the importance of consumption, suggesting a positive outlook for the sector [4]. - Key investment opportunities include the restaurant chain sector, which is nearing the end of price wars, and companies like Anjiexin Foods and Lihai Foods are seeing improved net profit margins [4]. Group 2: Duty-Free Industry Insights - Hainan's duty-free sales data shows a significant recovery in Q3 2025, with a notable increase in average transaction value, and a stable outlook for Q4 [5]. - Continuous policy support, including a clear timeline for the island's closure and an expanded range of duty-free products, is expected to enhance the operational conditions for companies like China Duty Free Group and Hainan Development [5]. Group 3: Structural Upgrades in Consumption - The toy industry is evolving with IP incubation and category innovation, favoring leading companies with strong design and supply chain capabilities [6]. - The beauty industry is integrating medical, beauty, and health services, which is expected to enhance customer spending and repeat purchases [6]. - The consumer industry is transitioning from "functional supply" to "scenario value supply," indicating a structural upgrade in brand consumer goods [6]. Group 4: New Consumption Trends - Four new consumption themes are emerging: 1. Brand globalization 2.0, focusing on pricing power and emerging markets [7]. 2. Emotional value sectors like trendy toys and pet products are expected to benefit from rising GDP per capita [7]. 3. AI-driven consumption in service sectors is showing potential for profitability [7]. 4. Channel transformation emphasizing user experience and operational efficiency, particularly in instant retail and cost-effective dining [7]. Group 5: High-Growth Opportunities in Emotional Consumption - The gold and jewelry sector is undergoing significant changes, with rising gold prices and a shift towards emotional consumption, suggesting opportunities in high-end and trendy gold segments [8]. - Retail e-commerce is focusing on offline retail transformation and AI-enabled cross-border e-commerce leaders [8]. - The cosmetics sector is seeing growth in domestic brands that meet emotional value and safety ingredient innovation [8]. - The medical beauty sector remains resilient, with opportunities in differentiated products and mergers in downstream medical beauty institutions [8].

证券日报网讯爱美客（300896）11月10日在互动平台回答投资者提问时表示，公司收购韩国REGEN公 司，从短期财务数据来看，其对整体业绩贡献尚处于初步阶段。公司的生产经营既要立足于当下，又要 关注长期可持续发展。从长期看，公司对产品线的布局和整合，适时提出国际化战略，全面提升核心竞 争力，是符合公司和广大股东长远利益的。 ...

Core Insights - The company, Aimeike, reported that as of October 31, 2025, the number of shareholders is expected to reach 57,448 [2] Summary by Category - **Company Information** - Aimeike has communicated to investors that the projected number of shareholders will be 57,448 by the end of October 2025 [2]

证券代码：300896 证券简称：爱美客 公告编号：2025-050 号 爱美客技术发展股份有限公司 关于召开 2025 年第三次临时股东会的提示性公告 爱美客技术发展股份有限公司（以下简称"公司"）于 2025 年 10 月 29 日在巨潮资 讯网（http://www.cninfo.com.cn）披露了《关于召开 2025 年第三次临时股东会的通 知》（公告编号 2025-049），公司将于 2025 年 11 月 13 日（星期四）下午 14:00 召开 2025 年第三次临时股东会（以下简称"本次会议"）。为保护投资者权益，方便公司股 东行使股东会表决权，现将有关事项再次提示如下： 一、召开会议的基本情况 1、股东会届次：2025 年第三次临时股东会 2、股东会的召集人：董事会 3、本次会议的召集、召开符合《中华人民共和国公司法》《深圳证券交易所创业 板股票上市规则》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司 规范运作》等法律、行政法规、部门规章、规范性文件及《公司章程》的有关规定。 4、会议时间： （1）现场会议时间：2025 年 11 月 13 日 14:00 （2）网络投票 ...

Group 1 - The medical beauty sector increased by 4.29% on November 10, with *ST Meigu leading the gains [1] - The Shanghai Composite Index closed at 4018.6, up 0.53%, while the Shenzhen Component Index closed at 13427.61, up 0.18% [1] - The main funds in the medical beauty sector saw a net inflow of 94.61 million yuan, while retail funds experienced a net outflow of 53.71 million yuan [1] Group 2 - *ST Meigu's closing price was 4.22 yuan, with a rise of 4.98% and a trading volume of 163,200 shares, amounting to a transaction value of 68.05 million yuan [1] - Aimeike's closing price was 156.50 yuan, with a rise of 4.92% and a trading volume of 110,400 shares, amounting to a transaction value of 173.27 million yuan [1] - Huaxi Biological's closing price was 51.46 yuan, with a rise of 3.37% and a trading volume of 40,500 shares, amounting to a transaction value of 207 million yuan [1]

Core Insights - The trading volume of Aimeike reached 1.708 billion yuan, marking the highest level since March 17, 2025 [2] - The latest stock price increased by 5.12%, with a turnover rate of 5.22% [2] - The previous trading day's total transaction volume was 465 million yuan [2] Company Overview - Aimeike Technology Development Co., Ltd. was established on June 9, 2004, with a registered capital of 3,025.92061 million yuan [2]

Core Viewpoint - The A-share market is experiencing volatility, but overall corporate earnings are in a recovery phase, with a positive medium-term outlook supported by stable economic and policy expectations [2][3]. Market Performance - As of November 10, 2025, the CSI 300 Index decreased by 0.24%, with notable stock movements including China Duty Free leading with a 10.00% increase and Sanhua Intelligent Control dropping by 7.02% [2]. - The CSI 300 ETF by Bosera fell by 0.33%, with a recent price of 1.52 yuan, while it saw a cumulative increase of 0.73% over the past week as of November 7 [2]. Investment Strategy - Analysts suggest focusing on sectors with independent growth logic and improving return on equity (ROE), rather than avoiding AI narratives entirely [3]. - The current market style is expected to be more balanced compared to the third quarter, with recommendations to invest in technology growth and high-end manufacturing sectors, as well as cyclical sectors benefiting from domestic demand recovery [3]. Sector Analysis - The TMT sector, along with materials and chemicals, is significantly influenced by AI narratives, with these sectors comprising over 60% of institutional holdings [3]. - The top ten weighted stocks in the CSI 300 Index as of October 31, 2025, include Ningde Times and Kweichow Moutai, accounting for 21.76% of the index [4].

Core Viewpoint - The retail and beauty care sectors are experiencing a collective surge, with several companies reaching their daily price limits, indicating strong market performance and investor interest [1] Group 1: Sector Performance - The retail and beauty care sectors are showing significant strength in the market [1] - Companies such as Yiyi Co., Dongbai Group, and China Duty Free have hit their daily price limits, reflecting robust investor confidence [1] - Other companies like Wangfujing, Lafang Family, and Aimeike are also experiencing upward movement in their stock prices, contributing to the overall positive trend in the sector [1]

Core Insights - The retail industry is experiencing a shift from value preservation to emotional value, with a focus on high-growth segments for investment opportunities [5][28] - The report maintains a positive outlook on the retail sector, emphasizing the importance of consumer insights and differentiated product offerings [5][28] Retail Market Overview - The retail index reported a slight increase of 0.31% during the week of November 3 to November 7, 2025, underperforming the Shanghai Composite Index, which rose by 1.08% [7][16] - Year-to-date, the retail index has increased by 4.20%, lagging behind the Shanghai Composite Index's 19.27% growth [16][20] Investment Strategy for 2026 - The investment strategy highlights four main themes: 1. **Gold and Jewelry**: Focus on high-end and fashionable gold segments, with recommendations for brands like Lao Pu Gold and Chao Hong Ji [5][48] 2. **Retail E-commerce**: Emphasize the transformation of offline retail to enhance service and experience, with key players like Yonghui Supermarket and Ai Ying Shi [5][48] 3. **Cosmetics**: Target domestic brands that capture emotional value and innovate on safety ingredients, recommending brands like Juzi Biological and Pechoin [5][49] 4. **Medical Aesthetics**: Focus on differentiated product manufacturers and expanding medical institutions, with recommendations for brands like Ai Mei Ke and Ke Di-B [5][49] Sector Performance - The jewelry sector is undergoing significant changes due to rising gold prices and a decline in traditional wedding markets, leading to the emergence of brands with strong consumer insights [5][29] - The cosmetics sector is seeing a rise in domestic brands leveraging cultural roots and emotional value to capture market share [5][41] Company-Specific Insights - **Chao Hong Ji**: Reported a revenue increase of 28.4% year-on-year for the first three quarters of 2025, with a notable performance in Q3 [54] - **Yonghui Supermarket**: Experienced a revenue decline of 22.2% year-on-year for the first three quarters of 2025, but is undergoing significant transformation [50] - **Juzi Biological**: Achieved a revenue growth of 21.7% year-on-year for the first half of 2025, focusing on collagen products [50]